Geopolitics Alpha

8-K - Moleculin Biotech, Inc. (0001659617) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Moleculin Biotech filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: MBRX, XLV, XBI, LLY, JNJ
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Moleculin Biotech, Inc.(0001659617) (Filer)MBRXGEOPOLITICS ALPHA

8-K - Moleculin Biotech filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • MBRX Moleculin Biotech

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.

  • LLY Eli Lilly and

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.

  • JNJ Johnson & Johnson

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.

  • PFE Pfizer

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.

  • MRK Merck

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
MBRX+5.30%+0.18%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
XBI+4.20%+3.78%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
PFE+1.19%+1.90%baseafter closeafter closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001437749-26-037012 Size: 329 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Moleculin Biotech (MBRX) since “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” compared with the market

CompanyWhenMoveStatus
Johnson & Johnson (JNJ)three days earlier-1.97%final price
Johnson & Johnson (JNJ)five days earlier-1.35%final price
Eli Lilly (LLY)three days earlier-0.49%final price
Eli Lilly (LLY)five days earlier-2.25%final price
Moleculin Biotech (MBRX)three days earlier+0.18%final price
Moleculin Biotech (MBRX)five days earlier+5.30%final price
Merck (MRK)three days earlier-0.38%final price
Merck (MRK)five days earlier+0.65%final price
Pfizer (PFE)three days earlier+1.90%final price
Pfizer (PFE)five days earlier+1.19%final price
Spdr Series Trust (XBI)three days earlier+3.78%final price
Spdr Series Trust (XBI)five days earlier+4.20%final price
Select Sector Spdr Tr (XLV)three days earlier+0.04%final price
Select Sector Spdr Tr (XLV)five days earlier-0.28%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Moleculin Biotech (MBRX)

Companies tied to this story

  • MBRX Moleculin Biotech

    In “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Moleculin Biotech (MBRX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MBRX

  • XLV Select Sector Spdr Tr

    In “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story

  • XBI Spdr Series Trust

    Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Moleculin Biotech, Inc. (0001659617) (Filer).” Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story

  • LLY Eli Lilly

    Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Moleculin Biotech, Inc. (0001659617) (Filer).” Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story

  • JNJ Johnson & Johnson

    In “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story

  • PFE Pfizer

    Pfizer (PFE) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Moleculin Biotech, Inc. (0001659617) (Filer).” Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story

  • MRK Merck

    For “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story

How “8-K - Moleculin Biotech, Inc. (0001659617) (Filer)” reaches Moleculin Biotech (MBRX)

“8-K - Moleculin Biotech, Inc. (0001659617) (Filer)” (16 Nov 2026) reaches Moleculin Biotech (MBRX) through this story.

Moleculin Biotech (MBRX) is on the page because SEC 8-K filing -> direct issuer disclosure -> MBRX

Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story

Dates and price levels for Moleculin Biotech (MBRX)

MBRX traded between 0.23 and 10.04 across 20 sessions. The latest close on file is 8.16.

What the saved facts support for Moleculin Biotech (MBRX)

46 out of 100

“8-K - Moleculin Biotech, Inc. (0001659617) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.